药物诱导睡眠内镜期间崩的地点与多梦图内型特征有关
Sara Op de Beeck1,2, Daniel Vena3, Eli Van de Perck1
1Universiteit Antwerpen Faculteit geneeskunde en gezondheidswetenschappen, Translational Neurosciences, Wilrijk, Belgium.
Annals of the American Thoracic Society
|May 29, 2025
概括
在阻塞性睡眠呼吸暂停 (OSA) 中,呼吸道崩的不同部位与不同的病理生理特征有关. 了解这些联系,如 palatal 崩和增加的崩性,可能会改善非CPAP治疗结果.
科学领域:
- 睡眠医学 睡眠医学
- 呼吸系统生理学 呼吸系统生理学
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
背景情况:
- 阻塞性睡眠呼吸暂停 (OSA) 治疗结果受上呼吸道缩部位和病理生理特征的影响.
- 以前的研究将特定的崩模式 (例如,完全的集中口腔崩) 和特征 (例如,低兴奋值) 与降低的下神经刺激有效性联系起来.
- 呼吸道崩的解剖部位与OSA功能性内型特征之间的关系尚不清楚.
研究的目的:
- 为了研究药物诱导睡眠内镜 (DISE) 期间上呼吸道缩部位与OSA患者的特定病理生理内型特征之间的关联.
- 为了确定结构性崩模式是否与功能特征相关,如可崩性,唤醒值和扩展肌肉补偿.
主要方法:
- 对182名OSA患者进行了回顾性队列研究,这些患者接受了多睡眠图和DISE.
- DISE研究的得分均,以评估崩部位 (例如,口腔,侧壁,舌头底部,上).
- 内型特征 (循环增益,可折叠性,唤醒值,补偿) 从多睡眠学数据计算出来.
- 使用线性和多变量逻辑回归分析来量化崩类型和内型特征之间的关联,并对混因素进行调整.
主要成果:
- 完全的同心 palatal 崩 (CCCp) 独立地与增加的崩性和较低的兴奋值相关.
- 完整的舌头底部崩与较低的崩性相关,但激发值更高.
- 侧壁崩与扩张肌肉补偿的减少有关,而表关节崩与更大的补偿有关.
- 循环增益没有与任何特定的崩地点显示出显著的关联.
结论:
- 在OSA患者中,上呼吸道崩的不同部位具有独特的病理生理学内型特征.
- 在CCCp中增加的缩性和较低的兴奋值,以及在侧壁塌时减少的补偿,可能解释非CPAP疗法的较差结果.
- 这些发现强调了整合结构性和功能性评估对个性化OSA治疗策略的重要性.
相关概念视频
Sleep-Wake Cycles
1.6K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
1.6K
Sleepwalking and Sleep Talking
331
Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
331
Narcolepsy
205
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
205
Substance Use Disorders Affecting Sleep
225
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
225
Sedatives and Hypnotics Drugs: Miscellaneous Agents
249
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
249
REM Sleep Behavior Disorder
431
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
431


